<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03259477</url>
  </required_header>
  <id_info>
    <org_study_id>otw-20170804-02</org_study_id>
    <nct_id>NCT03259477</nct_id>
  </id_info>
  <brief_title>RFR Change of Precise Segmental Versus Complete Renal Arterial Clamping During LPN for Clinical T1 RCC</brief_title>
  <official_title>Renal Functional Reserve Change of Precise Segmental Versus Complete Renal Arterial Clamping During Laparoscopic Partial Nephrectomy for Clinical T1 Renal Cell Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xuanwu Hospital, Beijing</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xuanwu Hospital, Beijing</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Renal functional reserve may be better in patients with clinical T1 renal cell carcinoma(RCC)&#xD;
      undergoing laparoscopic partial nephrectomy with precise segmental renal artery clamping than&#xD;
      those with complete renal arterial clamping.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Renal functional reserve (RFR) describes the capacity of the intact nephron mass to increase&#xD;
      glomerular filtration rate(GFR) from baseline in response to stimuli (e.g., protein load).We&#xD;
      hypothesized that renal functional reserve may be better in patients with clinical T1 renal&#xD;
      cell carcinoma(RCC) undergoing laparoscopic partial(LPN) nephrectomy with precise segmental&#xD;
      renal artery clamping than those with complete renal arterial clamping.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Some participants with clinical T1 renal cell carcinoma(RCC) undergo precise segmental during laparoscopic partial nephrectomy and the others undergo complete renal arterial clamping.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Renal Functional Reserve change</measure>
    <time_frame>3 month after surgery.</time_frame>
    <description>Change in renal functional reserve after laparoscopic partial nephrectomy</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Renal Cell Carcinoma</condition>
  <arm_group>
    <arm_group_label>precise segmental clamping</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>These participants with clinical T1 renal cell carcinoma(RCC) undergo precise segmental renal arterial clamping during laparoscopic partial nephrectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>complete clamping</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>These participants with clinical T1 renal cell carcinoma(RCC) undergo complete renal arterial clamping during laparoscopic partial nephrectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>precise segmental renal arterial clamping</intervention_name>
    <description>Precise segmental renal artery clamping eliminates global renal ischemia by performing highly selective clamping of single or multiple segmental arteries.</description>
    <arm_group_label>precise segmental clamping</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic partial nephrectomy</intervention_name>
    <description>Laparoscopic partial nephrectomy (LPN) has been widely adopted as a minimally invasive nephron-sparing surgery for clinical T1 renal cell carcinoma(RCC).</description>
    <arm_group_label>complete clamping</arm_group_label>
    <arm_group_label>precise segmental clamping</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  1.Age ≥18 2.Estimated GFR &gt;30 mL/min/1.73m2 3.Anticipated intraoperative warm ischemic&#xD;
             time ≤30 min 4.Subjects who signed informed consent forms&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Allergy to iothalamate, shellfish or iodine&#xD;
&#xD;
          2. Use of metformin or amiodarone&#xD;
&#xD;
          3. intraoperative warm ischemic time &gt;30 min&#xD;
&#xD;
          4. Inability to maintain a stable regimen of medications which affect GFR for &gt; one week&#xD;
             prior to participation (e.g. non-steroidal anti-inflammatory drugs, angiotensin&#xD;
             converting enzyme inhibitors, angiotensin receptor blockers)&#xD;
&#xD;
          5. Use of medications which directly affect elimination of creatinine (e.g. cimetidine&#xD;
             and trimethoprim)&#xD;
&#xD;
          6. Acute exacerbation of asthma or chronic obstructive pulmonary disease within 3 months&#xD;
             requiring hospitalization or oral steroid therapy&#xD;
&#xD;
          7. Inadequate intravenous access&#xD;
&#xD;
          8. Severe anemia (Hct &lt;21%)&#xD;
&#xD;
          9. Acute kidney injury (rise in creatinine to ≥1.5 times the previous baseline or by ≥&#xD;
             0.3 mg/dL on most recent labs prior to enrollment)&#xD;
&#xD;
         10. History of contrast-induced nephropathy&#xD;
&#xD;
         11. Hyperthyroidism&#xD;
&#xD;
         12. Pheochromocytoma&#xD;
&#xD;
         13. Sickle cell disease&#xD;
&#xD;
         14. Urinary retention or incontinence&#xD;
&#xD;
         15. Status post organ transplant&#xD;
&#xD;
         16. Pregnancy or active breast feeding&#xD;
&#xD;
         17. Cognitive impairment with inability to give consent&#xD;
&#xD;
         18. Institutionalized status&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tongwen Ou, MD.</last_name>
    <role>Study Chair</role>
    <affiliation>Xuanwu Hospital, Beijing</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhenhua Shang, MD.</last_name>
    <phone>+8617801117318</phone>
    <email>shangzhenhua16@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hao Yan</last_name>
    <phone>+8683198448</phone>
    <email>outongwen1967@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Xuanwu Hospital Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhenhua Shang</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>August 21, 2017</study_first_submitted>
  <study_first_submitted_qc>August 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 23, 2017</study_first_posted>
  <last_update_submitted>April 27, 2020</last_update_submitted>
  <last_update_submitted_qc>April 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xuanwu Hospital, Beijing</investigator_affiliation>
    <investigator_full_name>ou tongwen</investigator_full_name>
    <investigator_title>chairman of urology</investigator_title>
  </responsible_party>
  <keyword>laparoscopic partial nephrectomy</keyword>
  <keyword>precise segmental renal arterial clamping</keyword>
  <keyword>renal cell carcinoma</keyword>
  <keyword>renal functional reserve</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Renal Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

